Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sapna P Patel

Showing results (51-60 of 125) with videos related to

Pageof 13
Sort By:
Therapeutic Advances in Medical Oncology|June 27, 2025
Pembrolizumab and all-trans retinoic acid combination treatment of advanced melanoma: long-term survival updateJessica S W Borgers, Theresa M Medina, William A Robinson, et al.
Melanoma Research|December 3, 2025
Adjuvant therapy in mucosal melanoma: a single-center experience and review of the literatureJane Mattei, Lin Ruitao, Michael A Davies, et al.
Melanoma Research|July 9, 2011
A phase II study of gefitinib in patients with metastatic melanomaSapna P Patel, Kevin B Kim, Nicholas E Papadopoulos, et al.
Cancer|September 29, 2024
Southwest Oncology Group S0826: A phase 2 trial of SCH 727965 (NSC 727135, dinaciclib) in patients with stage IV melanomaChristopher D Lao, James Moon, Vincent T Ma, et al.
Frontiers in Oncology|October 17, 2022
Intermittent MEK inhibition for the treatment of metastatic uveal melanomaShaheer Khan, Sapna P Patel, Alexander N Shoushtari, et al.
Neuro-Oncology Practice|July 15, 2024
Survival and treatment outcomes in patients with leptomeningeal disease from metastatic melanomaChantal Saberian, Denái R Milton, Julie Simon, et al.
American Journal of Clinical Oncology|March 7, 2018
Phase I/II Study of Hepatic Arterial Infusion of Nab-paclitaxel in Patients With Metastatic Melanoma to the LiverJesus Vera-Aguilera, Agop Y Bedikian, Roland L Bassett, et al.
Journal for Immunotherapy of Cancer|August 20, 2021
Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund's adjuvant (IFA) for resected high-risk melanomaSapna P Patel, Gina R Petroni, Jason Roszik, et al.
Biorxiv : the Preprint Server for Biology|January 31, 2024
Imipridones inhibit tumor growth and improve survival in an orthotopic liver metastasis mouse model of human uveal melanomaChandrani Chattopadhyay, Jason Roszik, Rajat Bhattacharya, et al.
Journal for Immunotherapy of Cancer|February 16, 2021
Influence of injection technique, drug formulation and tumor microenvironment on intratumoral immunotherapy delivery and efficacyNina M Muñoz, Malea Williams, Katherine Dixon, et al.
Pageof 13

Showing results (51-60 of 125) with videos related to

Sort By:
Pageof 13
Therapeutic Advances in Medical Oncology|June 27, 2025
Pembrolizumab and all-trans retinoic acid combination treatment of advanced melanoma: long-term survival updateJessica S W Borgers, Theresa M Medina, William A Robinson, et al.
Melanoma Research|December 3, 2025
Adjuvant therapy in mucosal melanoma: a single-center experience and review of the literatureJane Mattei, Lin Ruitao, Michael A Davies, et al.
Melanoma Research|July 9, 2011
A phase II study of gefitinib in patients with metastatic melanomaSapna P Patel, Kevin B Kim, Nicholas E Papadopoulos, et al.
Cancer|September 29, 2024
Southwest Oncology Group S0826: A phase 2 trial of SCH 727965 (NSC 727135, dinaciclib) in patients with stage IV melanomaChristopher D Lao, James Moon, Vincent T Ma, et al.
Frontiers in Oncology|October 17, 2022
Intermittent MEK inhibition for the treatment of metastatic uveal melanomaShaheer Khan, Sapna P Patel, Alexander N Shoushtari, et al.
Neuro-Oncology Practice|July 15, 2024
Survival and treatment outcomes in patients with leptomeningeal disease from metastatic melanomaChantal Saberian, Denái R Milton, Julie Simon, et al.
American Journal of Clinical Oncology|March 7, 2018
Phase I/II Study of Hepatic Arterial Infusion of Nab-paclitaxel in Patients With Metastatic Melanoma to the LiverJesus Vera-Aguilera, Agop Y Bedikian, Roland L Bassett, et al.
Journal for Immunotherapy of Cancer|August 20, 2021
Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund's adjuvant (IFA) for resected high-risk melanomaSapna P Patel, Gina R Petroni, Jason Roszik, et al.
Biorxiv : the Preprint Server for Biology|January 31, 2024
Imipridones inhibit tumor growth and improve survival in an orthotopic liver metastasis mouse model of human uveal melanomaChandrani Chattopadhyay, Jason Roszik, Rajat Bhattacharya, et al.
Journal for Immunotherapy of Cancer|February 16, 2021
Influence of injection technique, drug formulation and tumor microenvironment on intratumoral immunotherapy delivery and efficacyNina M Muñoz, Malea Williams, Katherine Dixon, et al.
Pageof 13